Chris Kilroy and Paul Mattick from Mercia, discuss the recent valuation uplifts in the EIS portfolio and the sale of two companies for over 8x cost of investment, in the last three months.
The discussion also covers:
– Removal of provisions introduced to recognise the risks of COVID-19 to portfolio companies
– The potential impact of the new national restrictions
– Progress in the Mercia EIS portfolio over the last six months
– The recent 8x exit of Clear Review that illustrates the potential when investing with Mercia